marijuana stock news

mCig, Inc. (MCIG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jul 31, 2015 Apr 30, 2015 Jan 31, 2015 Oct 31, 2014
Total Revenue 369   66   88   249  
Cost of Revenue 242 208 28 117
Gross Profit 127   (142) 61   132  
Operating Expenses
Research Development – 37 – –
Selling General and Administrative 788 1,507 803 901
Non Recurring – – – –
Others 2 1 2 2
Total Operating Expenses – – – –
Operating Income or Loss (663) (1,687) (744) (771)
Income from Continuing Operations
Total Other Income/Expenses Net – (639) – –
Earnings Before Interest And Taxes (663) (2,326) (744) (771)
Interest Expense – – – –
Income Before Tax (663) (2,326) (744) (771)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (663) (2,326) (744) (771)
Non-recurring Events
Discontinued Operations – 36 – (8)
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (663) (2,290) (744) (779)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (663) (2,290) (744) (779)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Lifeist Wellness Inc. (LFST) CannMart Partners with Other People’s Pot and Spiffy to Further Accelerate Roilty Growth

Lifeist’s CannMart Partners with Other People’s Pot and Spiffy to Further Accelerate…

$PNTV Succeeds in the Motions to Dismiss the Company’s $150 Million Complaint Against Comcast

Players Network Succeeds in the Motions to Dismiss the Company’s $150 Million…

Aurora Cannabis (ACB) Launches Innovative Infused Pre-Rolls with 50%+ THC for Medical Cannabis Patients

Aurora Launches Innovative Infused Pre-Rolls with 50%+ THC for Medical Cannabis Patients…

INSYS Therapeutics, Inc. (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD)

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment…